Acute Angle-Closure Glaucoma

1. Comprehensive Executive Overview

Acute Angle-Closure Glaucoma (AACG), classified under the ICD-10 code H40.21, is a critical, sight-threatening ophthalmic emergency. Unlike primary open-angle glaucoma, which is a slow, progressive, and often asymptomatic neuropathy, AACG is characterized by a sudden, rapid, and severe rise in intraocular pressure (IOP). This acute spike occurs due to a physical obstruction of the eye's drainage system, preventing the outflow of aqueous humor.

The eye continuously produces aqueous humor—a clear fluid that nourishes the anterior structures of the eye. In a healthy eye, this fluid drains through the iridocorneal angle, specifically passing through the trabecular meshwork into Schlemm's canal. In patients with AACG, this drainage angle becomes physically blocked by the peripheral iris.

[Aqueous Humor Production (Ciliary Body)]
│
▼
[Posterior Chamber] ──(Through Pupil)──► [Anterior Chamber]
│
▼
[Trabecular Meshwork]
│
[Blocked by Iris in AACG]
│
▼
[Severe IOP Elevation]

Without immediate clinical intervention, the sudden rise in IOP—often exceeding 50 to 70 mmHg (normal range is 10 to 21 mmHg)—leads to rapid, irreversible damage to the optic nerve, permanent visual field loss, and potentially complete blindness within hours. Consequently, recognizing the clinical presentation of an acute attack and initiating rapid medical and surgical decompression is paramount for any medical practitioner.

2. Detailed Pathophysiology, Etiology, and Risk Factors

Pathophysiology of Angle Closure

The fundamental pathophysiological mechanism underlying AACG is pupillary block.

1. Relative Pupillary Block: As the pupil undergoes mid-dilation, the contact between the posterior surface of the iris and the anterior capsule of the lens increases. This contact resists the flow of aqueous humor from the posterior chamber (where it is produced by the ciliary body) through the pupil into the anterior chamber.
2. Pressure Gradient Accumulation: Because fluid cannot easily pass through the pupil, pressure builds up in the posterior chamber behind the iris.
3. Iris Bombé: This localized pressure gradient pushes the peripheral iris forward.
4. Mechanical Occlusion: The forward-bulging iris physically drapes over and occludes the trabecular meshwork. This dynamic closure seals off the iridocorneal angle, completely halting aqueous drainage and causing an exponential, acute spike in IOP.

In rare cases, non-pupillary block mechanisms, such as plateau iris syndrome (where an anteriorly displaced ciliary body mechanically pushes the peripheral iris into the angle) or lens-induced (phacomorphic) mechanisms, can drive the closure.

   NORMAL ANGLE                      ANGLE-CLOSURE (Iris Bombé)

   [ Cornea ]                             [ Cornea ]
  /          \                           /          \
 /  Anterior  \                         /  Anterior  \
|   Chamber    |                       |   Chamber    |

====|====[Pupil]===|==== ====|====[Pupil]===|====
| Iris Iris | \ Iris Iris / <-- Iris bulges
\ Angle / _Angle__/ forward, blocking
_ [Mesh] __/ [Mesh] the drainage mesh

Etiology and Triggering Events

An acute attack is typically precipitated by sudden pupil dilation (mydriasis). In anatomically predisposed eyes, mid-dilation (around 4 to 6 mm) maximizes the contact between the lens and iris, while simultaneously relaxing the peripheral iris, allowing it to bunch up and block the angle.

Common triggers include:
* Dim Lighting Conditions: Watching a movie in a dark theater, driving at night, or transitioning into a dark room.
* Emotional Stress: High sympathetic nervous system activity causing physiological pupillary dilation.
* Pharmacological Agents:
* Adrenergic agonists (e.g., pseudoephedrine, phenylephrine used in cold remedies).
* Anticholinergics (e.g., atropine, ipratropium, antihistamines like diphenhydramine).
* Sulfa-based medications (e.g., topiramate, which causes ciliary body effusion and anterior displacement of the lens-iris diaphragm).
* Selective Serotonin Reuptake Inhibitors (SSRIs) and tricyclic antidepressants.

Anatomical Risk Factors

Not all eyes can develop angle closure; it requires a specific anatomical predisposition.

• Short Axial Length (Hyperopia): Far-sighted eyes are physically smaller, meaning the internal structures are crowded into a shallower anterior chamber.
• Shallow Anterior Chamber Depth: A distance of less than 2.5 mm from the corneal endothelium to the anterior lens surface significantly increases risk.
• Thick, Anteriorly Displaced Lens: As people age, the natural crystalline lens grows thicker and moves slightly forward, narrowing the physical space in the anterior segment.
• Narrow Iridocorneal Angle: Congenitally narrow drainage pathways.

Demographic Risk Factors

• Age: The risk increases significantly after age 50, primarily due to age-related cataractous changes and thickening of the lens.
• Biological Sex: Females are 3 to 4 times more likely to experience AACG than males, largely due to having shallower anterior chambers and shorter axial lengths on average.
• Ethnicity: Individuals of East Asian, Southeast Asian, and Inuit descent have a significantly higher prevalence of narrow angles and primary angle-closure glaucoma.
• Family History: A positive family history of angle-closure attacks indicates a strong genetic predisposition to the predisposing anatomical traits.

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation of acute angle-closure glaucoma is dramatic, painful, and highly classic. Unlike chronic glaucoma, patients are acutely aware that something is wrong.

Patient-Reported Symptoms

• Severe, Unilateral Ocular Pain: Often described as a deep, boring, excruciating ache in or around the affected eye.
• Ipsilateral Headache: The pain frequently radiates along the ophthalmic distribution of the trigeminal nerve, presenting as a severe brow ache or frontal headache.
• Systemic Autonomic Symptoms: Nausea, vomiting, and diaphoresis (profuse sweating) triggered by the profound vasovagal response to extreme intraocular pressure. These symptoms are so severe that patients sometimes present to emergency departments suspected of having acute abdominal or cardiac pathology.
• Rapid Blur/Loss of Vision: Severe reduction in visual acuity, often progressing to "hand motion" or "light perception" only.
• Halos Around Lights: Multi-colored, rainbow-like halos around light sources, caused by corneal epithelial edema.

Objective Clinical Signs (Physical Exam Findings)

Upon examination by an ophthalmologist or emergency physician, the following signs are typically present:
* Markedly Elevated Intraocular Pressure (IOP): IOP is typically between 40 and 80 mmHg. On digital palpation, the affected globe feels rock-hard compared to the normal eye.
* Ciliary Flush (Conjunctival Injection): Deep, violaceous circumcorneal injection of the conjunctival and episcleral vessels.
* Corneal Epithelial Edema: The cornea loses its normal clarity and appears "steamy," hazy, or cloudy due to fluid being forced into the corneal epithelium by high hydrostatic pressure.
* Mid-Dilated, Vertically Oval, Non-Reactive Pupil: The pupil is fixed in a mid-dilated state (typically 4–6 mm) and does not respond to light or accommodation. This is caused by localized ischemia of the iris sphincter muscle due to high pressure.
* Shallow Anterior Chamber: Slit-lamp examination reveals a highly shallow anterior chamber, with close apposition of the iris to the cornea.
* Mild Anterior Chamber Inflammation: Aqueous flare and inflammatory cells may be visible once corneal clarity allows visualization.

4. Standard Diagnostic Evaluation & Workup

A swift and precise diagnostic workup is critical. Delayed diagnosis directly correlates with permanent visual field loss due to optic nerve atrophy.

Suspected AACG Clinical Presentation
│
├──► Tonometry (Measure IOP; typically >40 mmHg)
├──► Slit-Lamp Exam (Assess cornea, pupil, anterior chamber depth)
└──► Gonioscopy (Gold Standard: Visualize occluded angle)
│
└───► Confirm Diagnosis (Shaffer Grade 0) ──► Initiate Immediate Treatment

1. Gonioscopy (The Gold Standard)

Gonioscopy is the definitive diagnostic test for angle-closure glaucoma. Using a specialized mirrored lens (such as a Goldmann, Posner, or Sussman 4-mirror goniolens) placed directly on the anesthetized cornea, the clinician can directly visualize the iridocorneal angle.

• Diagnostic Findings: In AACG, there is a complete absence of visualization of the normal angle structures (Schwalbe’s line, trabecular meshwork, scleral spur, and ciliary body band) in all four quadrants.
• Grading Systems: Clinicians use the Shaffer System or Spaeth System to grade the angle. A Shaffer Grade of 0 indicates a closed angle with iridocorneal contact.
• Compression/Indentation Gonioscopy: Using a small-diameter goniolens (like a Sussman lens), the clinician applies gentle pressure to the cornea. This pushes aqueous humor into the peripheral angle, artificially opening it. This technique allows the specialist to differentiate between appositional closure (reversible contact) and synechial closure (permanent adhesions or peripheral anterior synechiae [PAS]).

2. Tonometry

• Goldmann Applanation Tonometry (GAT): The clinical gold standard for measuring IOP. In an acute attack, GAT will register extremely high pressures, often above 50 mmHg.
• Note: Handheld tonometers (e.g., Tono-Pen, iCare) are highly useful when the patient is unable to sit at a slit lamp or when corneal edema prevents a clear applanation endpoint.

3. Slit-Lamp Biomicroscopy

• Van Herick Technique: A rapid, optical method used to estimate the anterior chamber depth before gonioscopy. A narrow slit beam is projected onto the cornea at a 60-degree angle at the limbus. If the gap between the corneal endothelium and the iris is less than 1/4 of the corneal thickness (Van Herick Grade 1 or less), the angle is highly prone to closure.
• Evaluation of the Optic Nerve (Ophthalmoscopy): If the cornea is clear enough, fundoscopy is performed to evaluate the optic nerve head. In an acute attack, the optic nerve may appear hyperemic and swollen. Long-term, permanent cupping (loss of the neuroretinal rim) will develop if the pressure is not rapidly relieved.

4. Advanced Anterior Segment Imaging

While not mandatory for initiating emergency treatment, these imaging modalities provide objective, high-resolution documentation of the angle anatomy:
* Anterior Segment Optical Coherence Tomography (AS-OCT): A non-contact imaging modality that provides rapid, cross-sectional, high-resolution images of the anterior chamber angle, confirming iridocorneal contact.
* Ultrasound Biomicroscopy (UBM): Uses high-frequency ultrasound to image the anterior segment. It is particularly useful for visualizing structures behind the iris, such as the ciliary body, helping to diagnose plateau iris syndrome or supraciliary effusions.

5. Therapeutic Interventions

The management of acute angle-closure glaucoma is a medical emergency divided into two distinct phases: immediate medical decompression to lower IOP and protect the optic nerve, followed by definitive surgical or laser resolution of the anatomical blockage.

Phase 1: Emergency Pharmacotherapy (Medical Decompression)

The primary goal of medical therapy is to rapidly lower the IOP to restore perfusion to the optic nerve and clear corneal edema so that definitive laser therapy can be performed. Multiple classes of medications are administered concurrently.

   EMERGENCY MEDICAL DECOMPRESSION REGIMEN

┌───────────────────────────────────────────────────┐
│ 1. Systemic Carbonic Anhydrase Inhibitors │
│ - Acetazolamide 500 mg IV or PO │
├───────────────────────────────────────────────────┤
│ 2. Topical Pressure-Lowering Drops │
│ - Beta-Blockers (Timolol 0.5%) │
│ - Alpha-2 Agonists (Brimonidine 0.15%) │
│ - Carbonic Anhydrase Inhibitors (Dorzolamide) │
├───────────────────────────────────────────────────┤
│ 3. Topical Miotics (Once IOP < 40 mmHg) │
│ - Pilocarpine 1% to 2% (constricts pupil) │
├───────────────────────────────────────────────────┤
│ 4. Systemic Osmotic Agents (If refractory) │
│ - IV Mannitol 20% (1-2 g/kg over 45 mins) │
└───────────────────────────────────────────────────┘

1. Systemic Carbonic Anhydrase Inhibitors (CAIs)

• Acetazolamide (Diamox): Typically administered as an immediate dose of 500 mg intravenously (IV) or two 250 mg tablets orally. This drug drastically reduces the production of aqueous humor by the ciliary body.
• Contraindications: Absolute contraindication in patients with a documented severe sulfa allergy or sickle cell disease.

2. Topical Antiglaucoma Medications

A combination of topical drops is administered immediately to suppress aqueous production and increase outflow:
* Beta-blockers: Timolol 0.5% (1 drop, repeated once). Reduces aqueous humor production. Use with caution in patients with severe asthma, COPD, or bradycardia.
* Alpha-2 Adrenergic Agonists: Brimonidine 0.15% or Apraclonidine 1% (1 drop). Decreases aqueous production and improves uveoscleral outflow.
* Topical CAIs: Dorzolamide 2% or Brinzolamide 1% (1 drop). Further suppresses aqueous production.

3. Topical Miotics (Parasympathomimetics)

• Pilocarpine 1% or 2%: Administered to induce miosis (pupil constriction). Constricting the pupil pulls the peripheral iris tissue away from the trabecular meshwork, physically opening the angle.
• Critical Clinical Consideration: Pilocarpine is ineffective when the IOP is extremely high (typically >40–50 mmHg) because the iris sphincter muscle becomes ischemic and unresponsive to cholinergic stimulation. Therefore, pilocarpine should only be instilled after the IOP has begun to decrease via systemic agents and topical beta-blockers.

4. Hyperosmotic Agents (Systemic)

• Intravenous Mannitol (20% solution): Administered at a dose of 1.0 to 2.0 g/kg body weight over 30 to 45 minutes. Mannitol increases the osmotic pressure of the plasma, drawing water out of the vitreous cavity into the bloodstream, rapidly shrinking the vitreous volume and lowering IOP.
• Contraindications/Precautions: Must be used with extreme caution in patients with congestive heart failure, renal insufficiency, or severe dehydration due to the risk of fluid overload and pulmonary edema.

Phase 2: Definitive Surgical and Laser Interventions

Once the intraocular pressure has been lowered to a safe level and the corneal edema has cleared sufficiently to allow visualization of the iris, definitive anatomical correction must be performed.

1. Laser Peripheral Iridotomy (LPI) - The Gold Standard

LPI is the definitive first-line treatment for primary angle closure caused by pupillary block.

• Procedure: Using a Nd:YAG laser, the ophthalmologist creates a small, permanent aperture in the peripheral iris (typically superiorly, under the upper eyelid, or temporally).
• Mechanism: This hole creates a direct pathway for aqueous humor to flow from the posterior chamber directly into the anterior chamber, bypassing the pupil. This immediately equalizes the pressure gradient between the two chambers, allowing the iris to fall backward into its normal, flat configuration, permanently opening the iridocorneal angle.

• Contralateral (Fellow) Eye Prophylaxis: Because the predisposing anatomical risk factors (shallow anterior chamber, short axial length) are bilateral, the fellow eye has a 50% to 80% chance of experiencing an acute angle-closure attack within 5 years. Therefore, prophylactic LPI of the contralateral eye is standard of care and should be performed promptly.

            LASER PERIPHERAL IRIDOTOMY (LPI)
  

  [ Cornea ] [ Cornea ]
  / \ / \
  / Anterior \ / Anterior \
  | Chamber | | Chamber |
  ====|====[Pupil]===|==== ====|====[Pupil]===|====
  \ Iris Iris / \ Iris * Iris / <-- * LPI (Laser Hole)
  __ [Mesh] / _[Mesh]___/ allows pressure
  (Blocked) (Angle Opens) equalization

2. Surgical Goniosynechialysis

If the angle remains closed after LPI due to the formation of permanent adhesions between the iris and the trabecular meshwork (Peripheral Anterior Synechiae - PAS), surgical goniosynechialysis may be performed. In this surgical procedure, the surgeon physically pulls the iris away from the trabecular meshwork using specialized micro-instruments in the operating room.

3. Lens Extraction (Cataract Surgery)

In recent years, early lens extraction has emerged as an exceptionally effective treatment for angle-closure glaucoma. The landmark EAGLE Trial (Effectiveness in Angle-closure Glaucoma of Clinical and Eye-care Evidence) demonstrated that clear lens extraction (cataract surgery) showed greater efficacy and was more cost-effective than LPI for patients with newly diagnosed primary angle closure and moderately elevated IOP.
* Mechanism: Replacing the thick, natural crystalline lens (typically 4.5 to 5.0 mm thick) with a micro-thin artificial intraocular lens (IOL, typically 1.0 mm thick) dramatically increases the physical volume of the anterior chamber, permanently opening the drainage angle and preventing future closure.

Long-Term Prognosis and Follow-Up

The long-term visual prognosis of AACG is directly proportional to the duration of the acute pressure spike.
* If diagnosed and treated within hours, most patients recover their baseline vision with minimal optic nerve damage.
* If the attack persists for days, permanent ischemic optic neuropathy, retinal vascular occlusions (central retinal vein or artery occlusion), and synechial angle closure will occur, resulting in permanent blindness or severe visual field restriction.
* Chronic Glaucoma Management: Many patients who survive an acute attack may still have damaged trabecular meshwork tissue. They require lifelong monitoring of their IOP, visual fields, and optic nerve optical coherence tomography (OCT) to manage secondary chronic glaucoma.

6. Frequently Asked Questions (FAQ)

Q1: What is the difference between open-angle and angle-closure glaucoma?

A: Open-angle glaucoma is a chronic, slow-progressing disease where the drainage angle of the eye remains physically open, but the microscopic drainage channels (trabecular meshwork) become clogged over time, leading to gradual, painless vision loss. Angle-closure glaucoma is an acute, sudden physical blockage of the entire drainage angle by the iris, causing an immediate, painful spike in pressure that requires emergency medical care.

Q2: Why is acute angle-closure glaucoma considered a medical emergency?

A: Because the intraocular pressure (IOP) rises to extreme levels (often triple the normal limit) in a matter of minutes or hours. This extreme pressure cuts off blood flow to the optic nerve and retinal cells. Without rapid decompression, permanent, irreversible blindness can occur within 24 to 48 hours.

Q3: Can certain medications trigger an attack of acute angle-closure glaucoma?

A: Yes. Any medication that causes the pupil to dilate (mydriasis) can trigger an attack in predisposed individuals with narrow angles. Common culprits include over-the-counter decongestants (pseudoephedrine), antihistamines (diphenhydramine), motion sickness patches (scopolamine), certain antidepressants (SSRIs and tricyclics), and the anti-seizure medication topiramate.

Q4: What does the pain of an acute glaucoma attack feel like?

A: The pain is typically described as an excruciating, deep, throbbing ache localized to one eye and the surrounding brow bone. It is often accompanied by a severe headache on the same side of the head, and it is so intense that it frequently induces severe nausea and vomiting.

Q5: What is Gonioscopy, and why is it crucial?

A: Gonioscopy is the gold-standard diagnostic test for glaucoma. It involves placing a specialized mirrored lens on the patient's numbed cornea to visualize the iridocorneal angle directly. It is the only way a doctor can definitively confirm whether the eye's drainage angle is open, narrow, or completely closed.

Q6: How does Laser Peripheral Iridotomy (LPI) treat this condition?

A: LPI uses a precise Nd:YAG laser to create a microscopic opening in the outer edge of the iris. This hole acts as a bypass valve, allowing trapped aqueous fluid to flow freely from behind the iris into the front of the eye. This equalizes pressure, causes the iris to flatten, and permanently re-opens the eye's natural drainage angle.

Q7: Why must the untreated "fellow eye" also receive laser treatment?

A: Because the predisposing factors for angle closure—such as a short eye length and a shallow anterior chamber—are anatomical and almost always affect both eyes. If one eye suffers an acute attack, the other "fellow" eye has up to an 80% chance of experiencing a similar life-altering attack. Prophylactic LPI of the healthy eye is highly safe and prevents future emergencies.

Q8: Can cataract surgery cure or prevent angle-closure glaucoma?

A: Yes, cataract surgery is highly effective. As we age, our natural lens thickens, pushing the iris forward and narrowing the drainage angle. Replacing this thick lens with a very thin, artificial intraocular lens (IOL) instantly increases the depth of the anterior chamber, permanently opening the drainage angle and virtually eliminating the risk of future angle-closure attacks.

Q9: What is the long-term prognosis after an acute episode?

A: The prognosis is excellent if the pressure is brought down within a few hours of symptom onset. However, if the pressure remains elevated for an extended period, it can lead to permanent optic nerve damage (glaucomatous optic neuropathy), chronic high pressure due to scar tissue (synechiae), and permanent vision loss. Lifelong follow-up with an ophthalmologist is essential.

Q10: What immediate first-aid steps should I take if I suspect an attack?

A: If you experience sudden, severe eye pain, blurred vision, halos around lights, and nausea, you must seek emergency medical care immediately. Do not take a nap or wait to see if the symptoms pass. Go directly to the nearest emergency room or an urgent care ophthalmology clinic. Do not patch the eye or apply pressure to it.

Related Clinical Integration

In a modern clinical setting, the management of Acute Angle-Closure Glaucoma requires a multidisciplinary approach that integrates precise diagnostic assessment with immediate pharmacological intervention. Clinicians must utilize a Tonometer (e.g., Goldmann applanation) / مقياس توتر العين (مثل غولدمان المسطح) (أجهزة دعم وتكبير الجراحة) to accurately quantify intraocular pressure, which is critical for confirming the diagnosis and monitoring the efficacy of emergency treatments such as Diamox / دياموكس 250 mg. While the primary focus remains on ophthalmological stabilization, healthcare professionals are encouraged to maintain broad clinical competency through rigorous testing and review, utilizing resources such as Orthopedic Prometric MCQs - Chapter 3 Part 14, Orthopedic Board Review MCQs: Spine & Scoliosis | Part 106, Orthopedic Surgery Mock Exam - Set B29D06, and Orthopedic Spine 2026 MCQs: Board Review Questions & Answers (Part 2) to ensure high standards of care across all surgical and diagnostic specialties within the hospital system.